M28 Capital Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-346,190
| Closed | -$3.68M | – | 12 |
|
|
2023
Q2 | $3.68M | Sell |
346,190
-186,700
| -35% | -$1.98M | 4.86% | 6 |
|
|
2023
Q1 | $4.44M | Buy |
532,890
+50,000
| +10% | +$417K | 5.02% | 8 |
|
|
2022
Q4 | $4.46M | Sell |
482,890
-39,660
| -8% | -$366K | 4.25% | 7 |
|
|
2022
Q3 | $6.71M | Sell |
522,550
-4,600
| -0.9% | -$59.1K | 7% | 4 |
|
|
2022
Q2 | $6.96M | Hold |
527,150
| – | – | 7.81% | 4 |
|
|
2022
Q1 | $11.1M | Hold |
527,150
| – | – | 10.2% | 4 |
|
|
2021
Q4 | $12.6M | Buy |
+527,150
| New | +$12.6M | 9.87% | 2 |
|